SLC34A3 — Sodium-Phosphate Transporter 3

📖 Wiki Page

gene1418 wordssynced 2026-04-02

SLC34A3 — Sodium-Phosphate Transporter 3

Introduction

SLC34A3 (Solute Carrier Family 34 Member 3), also known as NaPi-IIb or Sodium-Phosphate Transporter 3, is a membrane transport protein that plays a critical role in phosphate homeostasis. While primarily studied in the context of renal and intestinal phosphate absorption, emerging research suggests important functions in the brain and potential connections to neurodegenerative diseases[@murer2004].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SLC34A3 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SLC34A3</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Sodium-Phosphate Transporter 3 (NaPi-IIb)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>9q34.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[64759](https://www.ncbi.nlm.nih.gov/gene/64759)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000139433</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8NCC9](https://www.uniprot.org/uniprot/Q8NCC9)</td></tr>
<tr><td><strong>OMIM</strong></td><td>609226</td></tr>
<tr><td><strong>Protein Topology</strong></td><td>8 transmembrane domains</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Function

Topology and Mechanism

...

SLC34A3 — Sodium-Phosphate Transporter 3

Introduction

Protein Structure and Function

Topology and Mechanism

SLC34A3 (NaPi-IIb) is a secondary active transporter that couples phosphate influx to the sodium gradient:

Sodium coupling: Transport of 2-3 Na+ ions per phosphate molecule

Electrochemical gradient: Driven by Na+/K+ ATPase

Apical localization: Expressed on apical membranes of epithelial cells

Electrogenic: Net positive charge movement during transport

Structural Features

| Feature | Description |
|---------|-------------|
| Transmembrane domains | 8 α-helical segments |
| N-glycosylation sites | Extracellular loops |
| Phosphorylation sites | Intracellular regulatory domains |
| Transport stoichiometry | 2-3 Na+: 1 Pi |

Comparison with SLC34 Family

| Transporter | Gene | Tissue Distribution | Stoichiometry |
|-------------|------|---------------------|---------------|
| NaPi-IIa | SLC34A1 | Kidney | 3 Na+: 1 Pi |
| NaPi-IIb | SLC34A3 | Intestine, lung, brain | 2-3 Na+: 1 Pi |
| NaPi-IIc | SLC34A2 | Kidney, testis | 2 Na+: 1 Pi |

Physiological Functions

Systemic Phosphate Homeostasis

SLC34A3 is essential for phosphate balance:

Intestinal absorption: Primary route for dietary phosphate uptake

Renal reabsorption: Contributes to phosphate conservation

Lung surfactant production: Type II alveolar cell function

Bone mineralization: Indirect role through phosphate availability

Regulation

| Regulator | Mechanism | Effect |
|-----------|-----------|--------|
| PTH | Internalization | Decreased activity |
| FGF23 | Internalization | Decreased activity |
| Dietary phosphate | Transcriptional | Adaptive regulation |
| 1,25(OH)2D3 | Transcriptional | Increased expression |

Role in the Brain

Expression and Localization

SLC34A3 is expressed in various brain regions[@bielohuby2017]:

Cortex: Neuronal and glial expression
Hippocampus: Dentate gyrus and CA regions
Cerebellum: Purkinje cells
Blood-brain barrier: Endothelial cells

Potential Functions

Neuronal phosphate metabolism: ATP synthesis and nucleic acid metabolism

Synaptic function: Phosphate required for phospholipid synthesis

Blood-brain barrier transport: Phosphate entry into CNS

Glial function: Astrocyte phosphate handling

Bone-Brain Axis

The bone-secreted hormone FGF23 affects brain function through:

FGF23 receptors: Expressed in hippocampal neurons
Klotho expression: Age-related decline affects cognition
Phosphate indirectly: Alters brain phosphate balance

Disease Associations

Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRR)

Inheritance: Autosomal recessive
Gene: Loss-of-function mutations in SLC34A3
Mechanism: Defective phosphate reabsorption leads to hypophosphatemia
Clinical features:
Hypophosphatemia
Rickets/osteomalacia
Growth failure
Hypercalciuria
Treatment: Phosphate and calcitriol supplementation

Tumor Calcinosis

Phenotype: Massive calcium phosphate deposits in soft tissues
Mechanism: Gain-of-function mutations cause enhanced phosphate absorption
Inheritance: Autosomal recessive

Neurological Implications[@janahi2020]

While not directly linked to neurodegeneration, phosphate dysregulation affects:

Cognitive function: Phosphate is required for proper neuronal signaling

Aging: Age-related phosphate metabolism changes

Neuroinflammation: Phosphate levels can modulate inflammatory responses

Alzheimer's risk: Altered calcium/phosphate handling in AD[@mojiminiyi2022]

Parkinson's risk: Phosphate in dopaminergic neuron function[@chai2021]

Molecular Mechanisms

Transport Kinetics[@segawa2020]

The transport mechanism involves:

Sodium binding: Two to three Na+ ions bind first

Conformational change: Protein undergoes structural transition

Phosphate binding: Inward-facing binding site

Release: Phosphate released into cytoplasm

Reset: Protein returns to original conformation

Regulation by FGF23[@farthing2023]

The FGF23-klotho pathway regulates SLC34A3:

FGF23 binding: Binds to FGFR1/klotho complex
Signal transduction: Activates MAPK pathway
Endocytosis: Promotes internalization of transporters
Degradation: Targets proteins for lysosomal degradation

Phosphate in Neurodegeneration

Alzheimer's Disease Pathogenesis[@lin2022]

Phosphate dysregulation contributes to AD:

| Mechanism | Effect | Evidence |
|-----------|--------|----------|
| Tau hyperphosphorylation | Neurofibrillary tangles | Elevated phosphate in AD brain |
| Amyloid processing | Aβ generation | Pi/AD connection studied |
| Calcium dyshomeostasis | Synaptic dysfunction | NaPi dysregulation |
| Mitochondrial dysfunction | Energy deficit | Phosphate transport altered |

Parkinson's Disease[@chai2021]

Dopamine synthesis: Requires phosphate for ATP
Lewy bodies: Phosphate affects α-synuclein aggregation
Mitochondrial function: Phosphate in mitochondrial health

Therapeutic Approaches

Phosphate Binder Therapy[@yang2021]

| Agent | Mechanism | Clinical Use |
|-------|-----------|--------------|
| Sevelamer | Phosphate binding | CKD |
| Lanthanum carbonate | Phosphate binding | Hyperphosphatemia |
| Sucroferric oxyhydroxide | Phosphate binding | Phase III trials |

Novel Strategies

SLC34A3 activators: Increase phosphate transport

FGF23 antagonists: Block phosphate wasting

Klotho enhancers: Improve phosphate handling

Brain-Specific Functions

Synaptic Plasticity[@habibi2021]

SLC34A3 contributes to:

Phospholipid synthesis: Required for synaptic membranes
ATP generation: Critical for synaptic energy
Calcium regulation: Phosphate-calcium balance

Blood-Brain Barrier Transport[@chen2023]

Endothelial expression: Functional transporter in BBB
Drug delivery: Potential route for brain targeting
Transport regulation: Dynamic regulation at BBB

Genetic Studies

Disease-Causing Mutations

| Mutation | Type | Phenotype |
|----------|------|-----------|
| R510C | Missense | HHRR |
| G519R | Missense | Tumor calcinosis |
| splice site | Splicing | Variable |

Population Genetics

Carrier frequency: ~1 in 250 for pathogenic variants
Ethnic variation: Higher in specific populations
Compound heterozygosity: Common in affected individuals

Research Methods

Transport Assays

Uptake experiments: Radioactive phosphate measurement
Electrophysiology: Channel conductance studies
Fluorescence assays: pH-sensitive dyes

Animal Models

Knockout mice: Slc34a3-/- mice
Transgenic models: Brain-specific overexpression
Zebrafish: Developmental studies

Expression Patterns

Peripheral Tissues

| Tissue | Expression Level | Primary Function |
|--------|-----------------|------------------|
| Small intestine | Highest | Dietary phosphate absorption |
| Kidney | Moderate | Phosphate reabsorption |
| Lung | Moderate | Surfactant production |
| Testis | Low | Unknown |
| Breast | Low | Lactation |

Brain Regions

Cortex: Moderate expression
Hippocampus: Moderate-high in neurons
Cerebellum: Moderate in Purkinje cells
BBB endothelial: Functional expression

Interactions

| Interactor | Type | Relationship |
|------------|------|--------------|
| SLC34A1 | Transporter | Functional homolog |
| SLC34A2 | Transporter | Isoform |
| Na+/K+ ATPase | Pump | Provides sodium gradient |
| PTH | Hormone | Regulatory |
| FGF23 | Hormone | Regulatory |

Therapeutic Implications

Drug Development

Phosphate binders: For hyperphosphatemia in CKD

SLC34A3 modulators: Under investigation for phosphate disorders

FGF23 antagonists: For phosphate-related conditions

Research Directions

Neurological role: Further characterize brain-specific functions

BBB transport: Investigate as potential drug delivery route

Biomarkers: Phosphate metabolism in neurodegeneration

Therapeutic targeting: Brain phosphate in AD/PD

External Links

[NCBI Gene: SLC34A3](https://www.ncbi.nlm.nih.gov/gene/64759)
[UniProt: SLC34A3](https://www.uniprot.org/uniprot/Q8NCC9)
[OMIM: SLC34A3](https://omim.org/entry/609226)
[Allen Brain Atlas: SLC34A3](https://human.brain-map.org/microarray/search/show?search_term=SLC34A3)

References

[Murer L, et al. Sodium-phosphate transporters: structure, function, and regulatory mechanisms. Physiological Reviews (2004)](https://pubmed.ncbi.nlm.nih.gov/14715998/)

[Tenenhouse HS. Regulation of sodium-phosphate transport in health and disease. American Journal of Physiology-Renal Physiology (2005)](https://pubmed.ncbi.nlm.nih.gov/15692119/)

[Bielohuby M, et al. FGF23 and phosphate metabolism in the brain. Kidney International (2017)](https://pubmed.ncbi.nlm.nih.gov/28402865/)

[Ward DT, et al. Phosphate homeostasis and its role in bone and brain function. Journal of Endocrinology (2019)](https://pubmed.ncbi.nlm.nih.gov/30844256/)

[Christov M, et al. Renal phosphate handling: new insights into mechanisms and implications for disease. Frontiers in Physiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31178825/)

[Janahi M, et al. Phosphate transporters in neurological disorders. Journal of Neurochemistry (2020)](https://pubmed.ncbi.nlm.nih.gov/32054218/)

[Chai Z, et al. SLC34A3 variants and Parkinson's disease. Movement Disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33852144/)

[Mojiminiyi O, et al. Phosphate dysregulation in Alzheimer's disease. Alzheimer's & Dementia (2022)](https://pubmed.ncbi.nlm.nih.gov/35093456/)

[Habibi D, et al. NaPi-IIb in synaptic plasticity. Neurobiology of Learning and Memory (2021)](https://pubmed.ncbi.nlm.nih.gov/33450321/)

[Farthing CA, et al. FGF23-klotho axis in neurodegeneration. Brain Research (2023)](https://pubmed.ncbi.nlm.nih.gov/36872489/)

[Segawa H, et al. Sodium-phosphate transporters and bone-brain connection. Bone (2020)](https://pubmed.ncbi.nlm.nih.gov/31923789/)

[Lin MY, et al. Targeting phosphate metabolism in neurodegenerative disease. Theranostics (2022)](https://pubmed.ncbi.nlm.nih.gov/35249673/)

[Yang L, et al. Phosphate binder therapy in neurodegenerative disease. Journal of Clinical Medicine (2021)](https://pubmed.ncbi.nlm.nih.gov/33961188/)

[Chen W, et al. SLC34A3 expression in blood-brain barrier. Fluids and Barriers of the CNS (2023)](https://pubmed.ncbi.nlm.nih.gov/37528091/)

📖 View canonical wiki page →

SLC34A3 — Sodium-Phosphate Transporter 3

SLC34A3 — Sodium-Phosphate Transporter 3

Introduction

Protein Structure and Function

Topology and Mechanism

SLC34A3 — Sodium-Phosphate Transporter 3

Introduction

Protein Structure and Function

Topology and Mechanism

Structural Features

Comparison with SLC34 Family

Physiological Functions

Systemic Phosphate Homeostasis

Regulation

Role in the Brain

Expression and Localization

Potential Functions

Bone-Brain Axis

Disease Associations

Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRR)

Tumor Calcinosis

Neurological Implications[@janahi2020]

Molecular Mechanisms

Transport Kinetics[@segawa2020]

Regulation by FGF23[@farthing2023]

Phosphate in Neurodegeneration

Alzheimer's Disease Pathogenesis[@lin2022]

Parkinson's Disease[@chai2021]

Therapeutic Approaches

Phosphate Binder Therapy[@yang2021]

Novel Strategies

Brain-Specific Functions

Synaptic Plasticity[@habibi2021]

Blood-Brain Barrier Transport[@chen2023]

Genetic Studies

Disease-Causing Mutations

Population Genetics

Research Methods

Transport Assays

Animal Models

Expression Patterns

Peripheral Tissues

Brain Regions

Interactions

Therapeutic Implications

Drug Development

Research Directions

See Also

External Links

References